TUMOR-ASSOCIATED ANTIGEN B132

摘要

The invention relates to the tumor-associated antigen B132, to the immunogenic peptides derived therefrom and to the DNA molecules encoding the same. The invention further relates to the use thereof in the immunotherapy of cancer diseases and as a target molecule for chemotherapeutical intervention.